Heart medication converts cancer cells into vaccine

Heart medication converts cancer cells into vaccine
A class of heart medications, cardiac glycosides, can induce immunogenic cell death, whereby dying cancer cells are converted into a vaccine that stimulates antitumor response, according to a study published in the July 18 issue of Science Translational Medicine.

(HealthDay) -- A class of heart medications, cardiac glycosides, can induce immunogenic cell death (ICD), whereby dying cancer cells are converted into a vaccine that stimulates antitumor response, according to a study published in the July 18 issue of Science Translational Medicine.

Laurie Menger, from INSERM U848 in Villejuif, France, and colleagues developed and used an automated epifluorescence microscopy-based platform to identify inducers of ICD.

The researchers found that cardiac glycosides were potent inducers of ICD, and this effect correlated with inhibition of sodium and potassium-dependent adenosine triphosphatase. Their anti-cancer effect was observed in combination with DNA-damaging agents only in immunocompetent mice, and cancer cells treated with chemotherapy and cardiac glycosides were effective as a vaccine in mice challenged with live of the same type. In addition, a retrospective analysis of 145 cancer patients treated with a cardiac glycoside and 290 cancer patients who did not receive the drug showed improved five-year survival in patients treated with the cardiac glycoside (hazard ratio, 0.62).

"It will be interesting to determine the ICD-inducing capacity of large collections of to identify new drugs that elicit an immunological bystander effect," Menger and colleagues write. "Moreover, in the pipeline of drug discovery, it might be advisable to decide on the clinical development of compounds that share target and mechanism of action based on their (perhaps differential) ICD-stimulatory capacity."

Several of the authors hold a patent related to the study.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Certain heart meds may give chemo a boost

date Jul 18, 2012

(HealthDay) -- When common heart drugs such as digitalis and digoxin are combined with some chemotherapy drugs, the effect appears to be an increase in the death of cancer cells, according to French researchers.

Are ICDs up to par with patients living longer?

date Apr 04, 2011

Most patients with ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) who have an implantable cardioverter-defibrillator (ICD) now live more than seven years and those ICD patients with hereditary heart disease ...

Heart drugs show promise for fighting colon cancer

date Dec 16, 2009

Scientists in Sweden are reporting for the first time that a group of drugs used to treat heart failure shows promise for fighting colon cancer. The study is in ACS' Journal of Natural Products. Colon cancer ...

Recommended for you

Spicy treatment the answer to aggressive cancer?

date Jul 03, 2015

It has been treasured by food lovers for thousands of years for its rich golden colour, peppery flavour and mustardy aroma…and now turmeric may also have a role in fighting cancer.

Cancer survivors who smoke perceive less risk from tobacco

date Jul 02, 2015

Cancer survivors who smoke report fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who had quit before or after their diagnosis, according to a ...

Melanoma mutation rewires cell metabolism

date Jul 02, 2015

A mutation found in most melanomas rewires cancer cells' metabolism, making them dependent on a ketogenesis enzyme, researchers at Winship Cancer Institute of Emory University have discovered.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.